Dose-Constraint Model to Predict Neuroendocrine Dysfunction in Young Patients With Brain Tumors: Data From a Prospective Study.

[1]  E. Crowne,et al.  The hypothalamic-pituitary-adrenal axis in childhood cancer survivors. , 2018, Endocrine-related cancer.

[2]  A. Niemierko,et al.  Endocrine Deficiency As a Function of Radiation Dose to the Hypothalamus and Pituitary in Pediatric and Young Adult Patients With Brain Tumors. , 2018, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[3]  R. Sarin,et al.  Efficacy of Stereotactic Conformal Radiotherapy vs Conventional Radiotherapy on Benign and Low-Grade Brain Tumors: A Randomized Clinical Trial , 2017, JAMA oncology.

[4]  G. Armstrong,et al.  Endocrine Abnormalities in Aging Survivors of Childhood Cancer: A Report From the Childhood Cancer Survivor Study. , 2016, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[5]  C. Pui,et al.  Anterior hypopituitarism in adult survivors of childhood cancers treated with cranial radiotherapy: a report from the St Jude Lifetime Cohort study. , 2015, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[6]  Cinzia Talamonti,et al.  Organs at risk in the brain and their dose-constraints in adults and in children: a radiation oncologist's guide for delineation in everyday practice. , 2015, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[7]  N. Tarbell,et al.  Clinical outcomes and late endocrine, neurocognitive, and visual profiles of proton radiation for pediatric low-grade gliomas. , 2014, International journal of radiation oncology, biology, physics.

[8]  T. Merchant,et al.  Predicting the probability of abnormal stimulated growth hormone response in children after radiotherapy for brain tumors. , 2012, International Journal of Radiation Oncology, Biology, Physics.

[9]  T. Merchant,et al.  Growth hormone secretion after conformal radiation therapy in pediatric patients with localized brain tumors. , 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[10]  I. Pollack.  Multidisciplinary management of childhood brain tumors: a review of outcomes, recent advances, and challenges. , 2011, Journal of neurosurgery. Pediatrics.

[11]  M. Fisher,et al.  Pediatric Low-Grade Gliomas , 2009, Journal of child neurology.

[12]  S. Shalet,et al.  Hypopituitarism following Radiotherapy Revisited. , 2009, Endocrine development.

[13]  T. Merchant,et al.  Endocrine outcomes for children with embryonal brain tumors after risk-adapted craniospinal and conformal primary-site irradiation and high-dose chemotherapy with stem-cell rescue on the SJMB-96 trial. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[14]  T. Merchant,et al.  Multi-institution prospective trial of reduced-dose craniospinal irradiation (23.4 Gy) followed by conformal posterior fossa (36 Gy) and primary site irradiation (55.8 Gy) and dose-intensive chemotherapy for average-risk medulloblastoma. , 2003, International journal of radiation oncology, biology, physics.

[15]  S. Ashley,et al.  Fractionated stereotactic conformal radiotherapy following conservative surgery in the control of craniopharyngiomas. , 2007, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[16]  S. Puget,et al.  Pediatric craniopharyngiomas: classification and treatment according to the degree of hypothalamic involvement. , 2007, Journal of neurosurgery.

[17]  C. Thompson,et al.  Hypothalamic-pituitary dysfunction after irradiation of nonpituitary brain tumors in adults. , 2005, The Journal of clinical endocrinology and metabolism.

[18]  L. Adan,et al.  Seqüelas endócrinas da radioterapia no tratamento do câncer na infância e adolescência , 2005 .

[19]  R. Packer,et al.  Endocrine outcome in children with medulloblastoma treated with 18 Gy of craniospinal radiation therapy. , 2004, Neuro-oncology.

[20]  D. Keene,et al.  Endocrine complications of pediatric brain tumors: case series and literature review. , 2002, Pediatric neurology.

[21]  A. Paulino.  Hypothyroidism in children with medulloblastoma: a comparison of 3600 and 2340 cGy craniospinal radiotherapy. , 2002, International journal of radiation oncology, biology, physics.

[22]  Thomas E Merchant,et al.  Radiation dose-volume effects on growth hormone secretion. , 2002, International journal of radiation oncology, biology, physics.

[23]  D. Finkelstein,et al.  Hypothalamic/pituitary function following high-dose conformal radiotherapy to the base of skull: demonstration of a dose-effect relationship using dose-volume histogram analysis. , 2001, International journal of radiation oncology, biology, physics.

[24]  H. Poulsen,et al.  Dosimetry and growth hormone deficiency following cranial irradiation of childhood brain tumors. , 1999, Medical and pediatric oncology.

[25]  E. Fliers,et al.  Long-term neuro-endocrine sequelae after treatment for childhood medulloblastoma. , 1998, European journal of cancer.

[26]  D. Shrieve,et al.  Intracranial germinoma: the case for lower dose radiation therapy. , 1997, International journal of radiation oncology, biology, physics.

[27]  Douglas L. Jones.  ICRU Report 50—Prescribing, Recording and Reporting Photon Beam Therapy , 1994 .

[28]  P. Rubin,et al.  Hypothalamic-pituitary dysfunction after radiation for brain tumors. , 1993, The New England journal of medicine.

[29]  H. Bloom,et al.  The treatment and long-term prognosis of children with intracranial tumors: a study of 610 cases, 1950-1981. , 1990, International journal of radiation oncology, biology, physics.